MacroGenics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 24.5 million compared to USD 11.1 million a year ago. Net loss was USD 38.01 million compared to USD 66.44 million a year ago.

Basic loss per share from continuing operations was USD 0.61 compared to USD 1.08 a year ago. Diluted loss per share from continuing operations was USD 0.61 compared to USD 1.08 a year ago.